Research & Clinical Trial News
Astera Cancer Care Enrolls First Patient as First Community Site in Pioneering Clinical Trial
Astera Cancer Care is proud to announce that we have enrolled our first patient in a groundbreaking first-in-human (FIH) clinical trial, becoming the first community site in the United States to do so.
Read More
First Patient in the World Enrolled in IDeate-Lung02 Trial
Astera Cancer Care, an independent, physician-owned multi-specialty oncology practice, has yet again achieved another significant milestone by enrolling the world’s first patient in phase 3 of the IDeate-Lung02 clinical trial.
Read More
Astera Cancer Care Introduces ALPHA3 Clinical Trial
Astera Cancer Care has collaborated with Allogene Therapeutics to revolutionize the landscape of CAR T cell therapy, particularly for patients with Large B-Cell Lymphoma (LBCL).
Read More
Enhancing Precision Medicine testing process in a Breast Cancer population of a Community Oncology Practice
This abstract was authored by Astera Cancer Care’s Ellen Ronnen, MD, and Melissa Cruz, LPN
Read More
Using an Electronic Capture Geriatric Assessment to Guide Rehabilitation Triage for Adults with Cancer During Systemic Therapy.
Based on research that took place at Astera Cancer Care, this abstract was authored by ReVital, astwith key support and co-authorship from Astera Cancer Care’s Ellen Ronnen, MD, and Rachel Carroll, APN-BC.
Read More